289 related articles for article (PubMed ID: 15597399)
1. Enantiomerically pure [1, 2-diamino-1-(4-fluorophenyl)butane]platinum(II) complexes: synthesis and antitumor activity against MCF-7 and MDA-MB 231 breast cancer and LnCaP/FGC prostate cancer cell lines.
Dullin A; Dufrasne F; Gelbcke M; Gust R
Arch Pharm (Weinheim); 2004 Dec; 337(12):654-67. PubMed ID: 15597399
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and cytotoxicity of enantiomerically pure [1,2-diamino-1-(4-fluorophenyl)-3-methylbutane]platinum(II) complexes.
Dullin A; Dufrasne F; Gelbcke M; Gust R
ChemMedChem; 2006 Jun; 1(6):644-53. PubMed ID: 16892405
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antitumor activity of enantiomerically pure [1,2-diamino-1-(4-fluorophenyl)propane]dichloroplatinum(II) complexes.
Dufrasne F; Gelbcke M; Schnurr B; Gust R
Arch Pharm (Weinheim); 2002 May; 335(5):229-39. PubMed ID: 12210780
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, in vitro cytotoxic and antiviral activity of cis-[Pt(R(-) and S(+)-2-alpha-hydroxybenzylbenzimidazole)2Cl2] complexes.
Gökçe M; Utku S; Gür S; Ozkul A; Gümüş F
Eur J Med Chem; 2005 Feb; 40(2):135-41. PubMed ID: 15694648
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and characterization of platinum(II) oxadiazoline complexes and their in vitro antitumor activity in platinum-sensitive and -resistant cancer cell lines.
Coley HM; Sarju J; Wagner G
J Med Chem; 2008 Jan; 51(1):135-41. PubMed ID: 18072719
[TBL] [Abstract][Full Text] [Related]
6. Mono- and polynuclear [alkylamine]platinum(II) complexes of [1,2-bis(4-fluorophenyl)ethylenediamine]platinum(II): synthesis and investigations on cytotoxicity, cellular distribution, and DNA and protein binding.
Kapp T; Dullin A; Gust R
J Med Chem; 2006 Feb; 49(3):1182-90. PubMed ID: 16451082
[TBL] [Abstract][Full Text] [Related]
7. Relationship between anticancer activity and stereochemistry of saldach ligands and their iron(III) complexes.
Hille A; Gust R
Arch Pharm (Weinheim); 2009 Nov; 342(11):625-31. PubMed ID: 19882691
[TBL] [Abstract][Full Text] [Related]
8. [N-ethyl- and [N,N'-diethyl-1,2-bis(2,6-difluoro-3-hydroxyphenyl)-ethylenediamine]dichloroplatinum(II): structure and cytotoxic/estrogenic activity in breast cancer cells.
Gust R; Niebler K; Schönenberger H
J Med Chem; 2005 Nov; 48(23):7132-44. PubMed ID: 16279771
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and cytotoxic activities of estrone and estradiol cis-dichloroplatinum(II) complexes.
Kvasnica M; Rarova L; Oklestkova J; Budesinsky M; Kohout L
Bioorg Med Chem; 2012 Dec; 20(24):6969-78. PubMed ID: 23142322
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization and cytotoxicity of ammine/ethylamine platinum(II) complexes with carboxylates.
Zhang J; Li Y; Sun J
Eur J Med Chem; 2009 Jun; 44(6):2758-62. PubMed ID: 19056150
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of 17beta-estradiol-platinum(II) hybrid molecules showing cytotoxic activity on breast cancer cell lines.
Provencher-Mandeville J; Descôteaux C; Mandal SK; Leblanc V; Asselin E; Bérubé G
Bioorg Med Chem Lett; 2008 Apr; 18(7):2282-7. PubMed ID: 18356047
[TBL] [Abstract][Full Text] [Related]
12. Platinum-based antitumor drugs containing enantiomerically pure alpha-trifluoromethyl alanine as ligand.
Margiotta N; Papadia P; Lazzaro F; Crucianelli M; De Angelis F; Pisano C; Vesci L; Natile G
J Med Chem; 2005 Dec; 48(24):7821-8. PubMed ID: 16302821
[TBL] [Abstract][Full Text] [Related]
13. Development of cobalt(3,4-diarylsalen) complexes as tumor therapeutics.
Gust R; Ott I; Posselt D; Sommer K
J Med Chem; 2004 Nov; 47(24):5837-46. PubMed ID: 15537341
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization and antiproliferative studies of the enantiomers of cis-[(1,2-camphordiamine)dichloro]platinum(II) complexes.
Montaña AM; Bernal FJ; Lorenzo J; Farnós C; Batalla C; Prieto MJ; Moreno V; Avilés FX; Mesas JM; Alegre MT
Bioorg Med Chem; 2008 Feb; 16(4):1721-37. PubMed ID: 18036822
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of 17beta-estradiol-linked platinum(II) complexes and their cytocidal activity on estrogen-dependent and -independent breast tumor cells.
Perron V; Rabouin D; Asselin E; Parent S; C-Gaudreault R; Bérubé G
Bioorg Chem; 2005 Feb; 33(1):1-15. PubMed ID: 15668178
[TBL] [Abstract][Full Text] [Related]
16. Anticancer SAR models for MCF-7 and MDA-MB-231 breast cell lines.
Qamar S; Carrasquer CA; Cunningham SL; Cunningham AR
Anticancer Res; 2011 Oct; 31(10):3247-52. PubMed ID: 21965732
[TBL] [Abstract][Full Text] [Related]
17. Platinum(II) complexes with l-methionylglycine and l-methionyl-l-leucine ligands: synthesis, characterization and in vitro antitumoral activity.
Kaluderović GN; Schmidt H; Paschke R; Kalinowski B; Dietrich A; Mueller T; Steinborn D
J Inorg Biochem; 2007 Mar; 101(3):543-9. PubMed ID: 17223197
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and in vitro pharmacological behavior of platinum(II) complexes containing 1,2-diamino-1-(4-fluorophenyl)-2-alkanol ligands.
Würtenberger I; Angermaier B; Kircher B; Gust R
J Med Chem; 2013 Oct; 56(20):7951-64. PubMed ID: 24050157
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization and antitumor activity of new type binuclear platinum(II) complexes.
Zhang J; Liu L; Gong Y; Zheng X; Yang M; Cui J; Shen S
Eur J Med Chem; 2009 May; 44(5):2322-7. PubMed ID: 18524422
[TBL] [Abstract][Full Text] [Related]
20. Cisplatinum and transplatinum complexes with benzyliminoether ligands; synthesis, characterization, structure-activity relationships, and in vitro and in vivo antitumor efficacy.
Sbovata SM; Bettio F; Mozzon M; Bertani R; Venzo A; Benetollo F; Michelin RA; Gandin V; Marzano C
J Med Chem; 2007 Sep; 50(19):4775-84. PubMed ID: 17713897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
